Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation

X. Liu, Z. Yue, J. Yu, E. Daguindau, K. Kushekhar, Q. Zhang, Y. Ogata, P. R. Gafken, Y. Inamoto, A. Gracon, D. S. Wilkes, J. A. Hansen, S. J. Lee, J. Y. Chen, Sophie Paczesny

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Improved diagnostic methods are needed for bronchiolitis obliterans syndrome (BOS), a serious complication after allogeneic hematopoietic cell transplantation (HCT) and lung transplantation. For protein candidate discovery, we compared plasma pools from HCT transplantation recipients with BOS at onset (n = 12), pulmonary infection (n = 16), chronic graft-versus-host disease without pulmonary involvement (n = 15) and no chronic complications after HCT (n = 15). Pools were labeled with different tags (isobaric tags for relative and absolute quantification), and two software tools identified differentially expressed proteins (≥1.5-fold change). Candidate proteins were further selected using a six-step computational biology approach. The diagnostic value of the lead candidate, matrix metalloproteinase 3 (MMP3), was evaluated by enzyme-linked immunosorbent assay in plasma of a verification cohort (n = 112) with and without BOS following HCT (n = 76) or lung transplantation (n = 36). MMP3 plasma concentrations differed significantly between patients with and without BOS (area under the receiver operating characteristic curve 0.77). Consequently, MMP3 represents a potential noninvasive blood test for diagnosis of BOS.

Original languageEnglish (US)
Pages (from-to)2342-2351
Number of pages10
JournalAmerican Journal of Transplantation
Volume16
Issue number8
DOIs
StatePublished - Aug 1 2016

Fingerprint

Bronchiolitis Obliterans
Lung Transplantation
Cell Transplantation
Matrix Metalloproteinases
Proteomics
Matrix Metalloproteinase 3
Lung
Proteins
Hematologic Tests
Graft vs Host Disease
Computational Biology
ROC Curve
Software
Transplantation
Enzyme-Linked Immunosorbent Assay
Infection

Keywords

  • basic (laboratory) research/science
  • biomarker
  • bone marrow/hematopoietic stem cell transplantation
  • bronchiolitis obliterans (BOS)
  • lung transplantation/pulmonology
  • translational research/science

ASJC Scopus subject areas

  • Immunology and Allergy
  • Medicine(all)
  • Pharmacology (medical)
  • Transplantation

Cite this

Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation. / Liu, X.; Yue, Z.; Yu, J.; Daguindau, E.; Kushekhar, K.; Zhang, Q.; Ogata, Y.; Gafken, P. R.; Inamoto, Y.; Gracon, A.; Wilkes, D. S.; Hansen, J. A.; Lee, S. J.; Chen, J. Y.; Paczesny, Sophie.

In: American Journal of Transplantation, Vol. 16, No. 8, 01.08.2016, p. 2342-2351.

Research output: Contribution to journalArticle

Liu, X, Yue, Z, Yu, J, Daguindau, E, Kushekhar, K, Zhang, Q, Ogata, Y, Gafken, PR, Inamoto, Y, Gracon, A, Wilkes, DS, Hansen, JA, Lee, SJ, Chen, JY & Paczesny, S 2016, 'Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation', American Journal of Transplantation, vol. 16, no. 8, pp. 2342-2351. https://doi.org/10.1111/ajt.13750
Liu, X. ; Yue, Z. ; Yu, J. ; Daguindau, E. ; Kushekhar, K. ; Zhang, Q. ; Ogata, Y. ; Gafken, P. R. ; Inamoto, Y. ; Gracon, A. ; Wilkes, D. S. ; Hansen, J. A. ; Lee, S. J. ; Chen, J. Y. ; Paczesny, Sophie. / Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation. In: American Journal of Transplantation. 2016 ; Vol. 16, No. 8. pp. 2342-2351.
@article{fec6f6f72a014f96b2f55c27b1937665,
title = "Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation",
abstract = "Improved diagnostic methods are needed for bronchiolitis obliterans syndrome (BOS), a serious complication after allogeneic hematopoietic cell transplantation (HCT) and lung transplantation. For protein candidate discovery, we compared plasma pools from HCT transplantation recipients with BOS at onset (n = 12), pulmonary infection (n = 16), chronic graft-versus-host disease without pulmonary involvement (n = 15) and no chronic complications after HCT (n = 15). Pools were labeled with different tags (isobaric tags for relative and absolute quantification), and two software tools identified differentially expressed proteins (≥1.5-fold change). Candidate proteins were further selected using a six-step computational biology approach. The diagnostic value of the lead candidate, matrix metalloproteinase 3 (MMP3), was evaluated by enzyme-linked immunosorbent assay in plasma of a verification cohort (n = 112) with and without BOS following HCT (n = 76) or lung transplantation (n = 36). MMP3 plasma concentrations differed significantly between patients with and without BOS (area under the receiver operating characteristic curve 0.77). Consequently, MMP3 represents a potential noninvasive blood test for diagnosis of BOS.",
keywords = "basic (laboratory) research/science, biomarker, bone marrow/hematopoietic stem cell transplantation, bronchiolitis obliterans (BOS), lung transplantation/pulmonology, translational research/science",
author = "X. Liu and Z. Yue and J. Yu and E. Daguindau and K. Kushekhar and Q. Zhang and Y. Ogata and Gafken, {P. R.} and Y. Inamoto and A. Gracon and Wilkes, {D. S.} and Hansen, {J. A.} and Lee, {S. J.} and Chen, {J. Y.} and Sophie Paczesny",
year = "2016",
month = "8",
day = "1",
doi = "10.1111/ajt.13750",
language = "English (US)",
volume = "16",
pages = "2342--2351",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation

AU - Liu, X.

AU - Yue, Z.

AU - Yu, J.

AU - Daguindau, E.

AU - Kushekhar, K.

AU - Zhang, Q.

AU - Ogata, Y.

AU - Gafken, P. R.

AU - Inamoto, Y.

AU - Gracon, A.

AU - Wilkes, D. S.

AU - Hansen, J. A.

AU - Lee, S. J.

AU - Chen, J. Y.

AU - Paczesny, Sophie

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Improved diagnostic methods are needed for bronchiolitis obliterans syndrome (BOS), a serious complication after allogeneic hematopoietic cell transplantation (HCT) and lung transplantation. For protein candidate discovery, we compared plasma pools from HCT transplantation recipients with BOS at onset (n = 12), pulmonary infection (n = 16), chronic graft-versus-host disease without pulmonary involvement (n = 15) and no chronic complications after HCT (n = 15). Pools were labeled with different tags (isobaric tags for relative and absolute quantification), and two software tools identified differentially expressed proteins (≥1.5-fold change). Candidate proteins were further selected using a six-step computational biology approach. The diagnostic value of the lead candidate, matrix metalloproteinase 3 (MMP3), was evaluated by enzyme-linked immunosorbent assay in plasma of a verification cohort (n = 112) with and without BOS following HCT (n = 76) or lung transplantation (n = 36). MMP3 plasma concentrations differed significantly between patients with and without BOS (area under the receiver operating characteristic curve 0.77). Consequently, MMP3 represents a potential noninvasive blood test for diagnosis of BOS.

AB - Improved diagnostic methods are needed for bronchiolitis obliterans syndrome (BOS), a serious complication after allogeneic hematopoietic cell transplantation (HCT) and lung transplantation. For protein candidate discovery, we compared plasma pools from HCT transplantation recipients with BOS at onset (n = 12), pulmonary infection (n = 16), chronic graft-versus-host disease without pulmonary involvement (n = 15) and no chronic complications after HCT (n = 15). Pools were labeled with different tags (isobaric tags for relative and absolute quantification), and two software tools identified differentially expressed proteins (≥1.5-fold change). Candidate proteins were further selected using a six-step computational biology approach. The diagnostic value of the lead candidate, matrix metalloproteinase 3 (MMP3), was evaluated by enzyme-linked immunosorbent assay in plasma of a verification cohort (n = 112) with and without BOS following HCT (n = 76) or lung transplantation (n = 36). MMP3 plasma concentrations differed significantly between patients with and without BOS (area under the receiver operating characteristic curve 0.77). Consequently, MMP3 represents a potential noninvasive blood test for diagnosis of BOS.

KW - basic (laboratory) research/science

KW - biomarker

KW - bone marrow/hematopoietic stem cell transplantation

KW - bronchiolitis obliterans (BOS)

KW - lung transplantation/pulmonology

KW - translational research/science

UR - http://www.scopus.com/inward/record.url?scp=84978880096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978880096&partnerID=8YFLogxK

U2 - 10.1111/ajt.13750

DO - 10.1111/ajt.13750

M3 - Article

VL - 16

SP - 2342

EP - 2351

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 8

ER -